
    
      A Dose-block Randomized, Double-blind, Placebo-controlled, Multiple Dosing, Dose-escalation
      Phase I Clinical Trial to Investigate the Safety/Tolerability and
      Pharmacokinetics/Pharmacodynamics of CKD-519 After Oral Administration in Healthy Adult
      Volunteers
    
  